Requires insurers to provide information on resources for insureds or enrollees recently diagnosed with Alzheimer's disease.
Summary
Bill S05842 amends the New York insurance law to require insurers to provide written informational resources to insureds or enrollees who have recently been diagnosed with Alzheimer's disease. The bill mandates that these resources be delivered within sixty days of notification of the diagnosis, whether through claims data or direct communication from the insured or enrollee. The information must include up-to-date, evidence-based content about Alzheimer's disease and contact details for organizations that specialize in support for individuals affected by the disease.
Impact
The passage of this bill would enhance the support structure for individuals diagnosed with Alzheimer's disease by ensuring they receive timely and relevant information about their condition. It would require insurers to adapt their communication practices, potentially leading to changes in how health information is disseminated to patients. This could also set a precedent for future legislation aimed at improving patient education and support in other health-related areas.
Sentiment
The sentiment around Bill S05842 appears to be generally positive, as it addresses a critical need for support and information for individuals diagnosed with Alzheimer's disease. There have been no recorded votes or significant opposition noted in the committee discussions, suggesting a consensus on the importance of the bill's objectives.
Contention
While the bill has garnered support for its intent to aid those diagnosed with Alzheimer's, there may be concerns regarding the implementation logistics, such as the effectiveness of the communication methods and the potential burden on insurers to provide these resources in a timely manner. Stakeholders in the insurance industry may have varying opinions on the feasibility of the requirements set forth in the bill.
Requires insurers to provide insurance coverage for treatment of rare diseases, life-threatening conditions or diseases, degenerative and disabling conditions, or diagnoses involving medically fragile children, by a provider of the patient's choice.